|
- FAQs About KEYTRUDA® (pembrolizumab)
Find answers to frequently asked questions about KEYTRUDA® (pembrolizumab) including how does KEYTRUDA work, PD-L1 testing information, and more
- How KEYTRUDA® (pembrolizumab) Works
Learn how KEYTRUDA® (pembrolizumab) works with your immune system to help fight cancer cells Watch two videos about immunotherapy and how it works in the body
- KEYTRUDA® (pembrolizumab) - Official Site
Learn about KEYTRUDA® (pembrolizumab), an immunotherapy that works with your immune system to help fight certain cancers Visit the patient website
- How KEYTRUDA® (pembrolizumab) Is Given
How do I take KEYTRUDA? Your doctor will give you KEYTRUDA into your vein through an intravenous (IV) line Treatments are given over 30 minutes Treatments usually take place at your doctor’s office or an infusion clinic
- Infusion Information and Resources for KEYTRUDA® (pembrolizumab)
View tips and resources that may help while receiving KEYTRUDA® (pembrolizumab) including what to expect with your first infusion appointment and what to know about your treatment schedule
- FDA Approved for Certain People With Non–Small Cell Lung . . . - KEYTRUDA
Patients who have been prescribed KEYTRUDA for an approved indication can access additional support from KEY+YOU, the patient support program for KEYTRUDA KEY+YOU helps eligible patients by offering educational resources and support information throughout treatment
- Side Effects of KEYTRUDA® (pembrolizumab)
Side effects of KEYTRUDA when used alone that are more common in children than in adults include: fever, vomiting, headache, stomach area (abdominal) pain, and low levels of white blood cells and red blood cells (anemia)
- Triple-Negative Breast Cancer (TNBC) - KEYTRUDA
It explains what KEYTRUDA is and how it works, contains questions to ask your care team before and after surgery, and has additional information to help you navigate your treatment plan including KEYTRUDA for high-risk early-stage TNBC
|
|
|